Patent ID: 8541456

Claim:
A pharmaceutical composition comprising a pharmaceutical formulation including a first amount of a compound of formula 1.1 or a pharmaceutically acceptable salt thereof and/or a compound of formula 1.2 or a pharmaceutically acceptable salt thereof, a second amount of a PPAR-agonist selected from the group consisting of MURAGLITAZAR, ROSIGLITAZONE, PIOGLITAZONE, RAGAGLITAZAR, FARGLITAZAR, TESAGLITAZAR, NAVEGLITAZAR, NETOGLITAZONE, RIVOGLITAZONE, K-111, GW-677954, FK-614, (−)-Halofenate and the pharmaceutically acceptable salts of these compounds, wherein the first amount and the second amount together comprise an effective amount for the treatment of diabetes mellitus type 2, and at least one pharmaceutically acceptable auxiliary.